Boston Scientific acquires Cryterion Medical, enters cryoablation market
Boston Scientific recently announced acquisition of Cryterion Medical, Inc., a company developing a cryoablation platform to treat atrial fibrillation (AF), positioning it in the growing electrophysiology market.





